Exact Therapeutics AS (OSL:EXTX) Equity-to-Asset : 0.74 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Exact Therapeutics AS Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Exact Therapeutics AS's Total Stockholders Equity for the quarter that ended in Dec. 2023 was kr45.10 Mil. Exact Therapeutics AS's Total Assets for the quarter that ended in Dec. 2023 was kr61.32 Mil.

The historical rank and industry rank for Exact Therapeutics AS's Equity-to-Asset or its related term are showing as below:

OSL:EXTX' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.42 Med: 0.81 Max: 0.94
Current: 0.74

During the past 7 years, the highest Equity to Asset Ratio of Exact Therapeutics AS was 0.94. The lowest was 0.42. And the median was 0.81.

OSL:EXTX's Equity-to-Asset is ranked better than
59.09% of 1567 companies
in the Biotechnology industry
Industry Median: 0.66 vs OSL:EXTX: 0.74

Exact Therapeutics AS Equity-to-Asset Historical Data

The historical data trend for Exact Therapeutics AS's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exact Therapeutics AS Equity-to-Asset Chart

Exact Therapeutics AS Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Equity-to-Asset

Get a 7-Day Free Trial

0.81

0.94

0.90

0.79

0.74

Exact Therapeutics AS Semi-Annual Data
	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Equity-to-Asset	Get a 7-Day Free Trial						0.90	0.84	0.79	0.85	0.74

Competitive Comparison of Exact Therapeutics AS's Equity-to-Asset

For the Biotechnology subindustry, Exact Therapeutics AS's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Exact Therapeutics AS's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Exact Therapeutics AS's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Exact Therapeutics AS's Equity-to-Asset falls into.

Exact Therapeutics AS Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Exact Therapeutics AS's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	45.101	/	61.319
	=

Exact Therapeutics AS's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	45.101	/	61.319
	=

Exact Therapeutics AS (OSL:EXTX) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Exact Therapeutics AS Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Exact Therapeutics AS's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Exact Therapeutics AS (OSL:EXTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exact Therapeutics AS (OSL:EXTX) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ostre Aker vei 19, Oslo, NOR, 0581

Website

https://www.exact-tx.com

Exact Therapeutics AS is a clinical-stage biotechnology company. It is developing a technology platform for therapeutic enhancement - Acoustic Cluster Therapy (ACT). ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement that will amplify the clinical utility of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions.

Exact Therapeutics AS (OSL:EXTX) Headlines

No Headlines